BioRender 아이콘

Syringe (small, 1/2 liquid)

Syringe (small, 1/2 liquid) - Editable icon of A small syringe with 1/2 liquid filled
[{"image":"https://icons.cdn.biorender.com/w75xh75/6792b4110a611cd8db18ca6d/5f63d36a19623700288c6a7a.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/6792b4110a611cd8db18ca6d/5f63d36a19623700288c6a7a.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/6792b4110a611cd8db18ca6e/5f63d36a19623700288c6a7a.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/6792b4110a611cd8db18ca6e/5f63d36a19623700288c6a7a.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/6792b4110a611cd8db18ca6f/5f63d36a19623700288c6a7a.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/6792b4110a611cd8db18ca6f/5f63d36a19623700288c6a7a.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/6792b4110a611cd8db18ca70/5f63d36a19623700288c6a7a.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/6792b4110a611cd8db18ca70/5f63d36a19623700288c6a7a.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/6792b4110a611cd8db18ca71/5f63d36a19623700288c6a7a.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/6792b4110a611cd8db18ca71/5f63d36a19623700288c6a7a.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/6792b4110a611cd8db18ca72/5f63d36a19623700288c6a7a.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/6792b4110a611cd8db18ca72/5f63d36a19623700288c6a7a.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/6792b4110a611cd8db18ca73/5f63d36a19623700288c6a7a.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/6792b4110a611cd8db18ca73/5f63d36a19623700288c6a7a.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/6792b4110a611cd8db18ca74/5f63d36a19623700288c6a7a.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/6792b4110a611cd8db18ca74/5f63d36a19623700288c6a7a.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/6792b4110a611cd8db18ca75/5f63d36a19623700288c6a7a.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/6792b4110a611cd8db18ca75/5f63d36a19623700288c6a7a.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/6792b4110a611cd8db18ca76/5f63d36a19623700288c6a7a.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/6792b4110a611cd8db18ca76/5f63d36a19623700288c6a7a.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/6792b4110a611cd8db18ca77/5f63d36a19623700288c6a7a.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/6792b4110a611cd8db18ca77/5f63d36a19623700288c6a7a.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/6792b4110a611cd8db18ca78/5f63d36a19623700288c6a7a.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/6792b4110a611cd8db18ca78/5f63d36a19623700288c6a7a.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/6792b4110a611cd8db18ca79/5f63d36a19623700288c6a7a.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/6792b4110a611cd8db18ca79/5f63d36a19623700288c6a7a.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/6792b4110a611cd8db18ca7a/5f63d36a19623700288c6a7a.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/6792b4110a611cd8db18ca7a/5f63d36a19623700288c6a7a.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/6792b4110a611cd8db18ca7b/5f63d36a19623700288c6a7a.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/6792b4110a611cd8db18ca7b/5f63d36a19623700288c6a7a.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/6792b4110a611cd8db18ca7c/5f63d36a19623700288c6a7a.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/6792b4110a611cd8db18ca7c/5f63d36a19623700288c6a7a.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/6792b4110a611cd8db18ca7d/5f63d36a19623700288c6a7a.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/6792b4110a611cd8db18ca7d/5f63d36a19623700288c6a7a.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/6792b4110a611cd8db18ca7e/5f63d36a19623700288c6a7a.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/6792b4110a611cd8db18ca7e/5f63d36a19623700288c6a7a.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/6792b4110a611cd8db18ca7f/5f63d36a19623700288c6a7a.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/6792b4110a611cd8db18ca7f/5f63d36a19623700288c6a7a.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/6792b4110a611cd8db18ca80/5f63d36a19623700288c6a7a.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/6792b4110a611cd8db18ca80/5f63d36a19623700288c6a7a.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/6792b4110a611cd8db18ca81/5f63d36a19623700288c6a7a.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/6792b4110a611cd8db18ca81/5f63d36a19623700288c6a7a.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/6792b4110a611cd8db18ca82/5f63d36a19623700288c6a7a.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/6792b4110a611cd8db18ca82/5f63d36a19623700288c6a7a.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/6792b4110a611cd8db18ca83/5f63d36a19623700288c6a7a.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/6792b4110a611cd8db18ca83/5f63d36a19623700288c6a7a.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/6792b4110a611cd8db18ca84/5f63d36a19623700288c6a7a.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/6792b4110a611cd8db18ca84/5f63d36a19623700288c6a7a.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/6792b4110a611cd8db18ca85/5f63d36a19623700288c6a7a.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/6792b4110a611cd8db18ca85/5f63d36a19623700288c6a7a.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/6792b4110a611cd8db18ca86/5f63d36a19623700288c6a7a.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/6792b4110a611cd8db18ca86/5f63d36a19623700288c6a7a.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/6792b4110a611cd8db18ca87/5f63d36a19623700288c6a7a.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/6792b4110a611cd8db18ca87/5f63d36a19623700288c6a7a.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/6792b4110a611cd8db18ca88/5f63d36a19623700288c6a7a.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/6792b4110a611cd8db18ca88/5f63d36a19623700288c6a7a.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/6792b4110a611cd8db18ca89/5f63d36a19623700288c6a7a.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/6792b4110a611cd8db18ca89/5f63d36a19623700288c6a7a.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/6792b4110a611cd8db18ca8a/5f63d36a19623700288c6a7a.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/6792b4110a611cd8db18ca8a/5f63d36a19623700288c6a7a.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/6792b4110a611cd8db18ca8b/5f63d36a19623700288c6a7a.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/6792b4110a611cd8db18ca8b/5f63d36a19623700288c6a7a.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/6792b4110a611cd8db18ca8c/5f63d36a19623700288c6a7a.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/6792b4110a611cd8db18ca8c/5f63d36a19623700288c6a7a.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/6792b4110a611cd8db18ca8d/5f63d36a19623700288c6a7a.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/6792b4110a611cd8db18ca8d/5f63d36a19623700288c6a7a.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/6792b4110a611cd8db18ca8e/5f63d36a19623700288c6a7a.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/6792b4110a611cd8db18ca8e/5f63d36a19623700288c6a7a.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/6792b4110a611cd8db18ca8f/5f63d36a19623700288c6a7a.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/6792b4110a611cd8db18ca8f/5f63d36a19623700288c6a7a.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/6792b4110a611cd8db18ca90/5f63d36a19623700288c6a7a.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/6792b4110a611cd8db18ca90/5f63d36a19623700288c6a7a.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/6792b4110a611cd8db18ca91/5f63d36a19623700288c6a7a.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/6792b4110a611cd8db18ca91/5f63d36a19623700288c6a7a.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/6792b4110a611cd8db18ca92/5f63d36a19623700288c6a7a.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/6792b4110a611cd8db18ca92/5f63d36a19623700288c6a7a.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/6792b4110a611cd8db18ca93/5f63d36a19623700288c6a7a.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/6792b4110a611cd8db18ca93/5f63d36a19623700288c6a7a.png"}]
이 아이콘 사용하기 – 무료
가입 시 신용카드가 필요하지 않습니다.

이 아이콘은 BioRender에서 자유롭게 편집할 수 있습니다

  • 텍스트, 도형 및 기타 아이콘 추가
  • 5만 개 이상의 과학적으로 정확한 아이콘을 검색하세요
  • 모든 아이콘, 선, 라벨의 색상과 배치를 자유롭게 변경하세요
  • 어떤 용도로든 내보내거나 공유하세요
Scientist Avatars

이미 출판용 수준의 그림을 만들고 있는 400만 명 이상의 과학자들과 함께하세요

아이콘으로 몇 분 만에 완성된 그림을 만들어 보세요

  • 검색 50,000개 이상의 과학적으로 정확하고 동료 검토를 거친 아이콘 제공
  • 맞춤 설정 라벨, 도형, 추가 아이콘을 사용하여 모든 요소를 자유롭게 편집할 수 있습니다.
  • 내보내기 또는 공동 작업자와 그림 공유하기
    ‍
page dashboard

찾으시는 아이콘이 아닌가요? 더 많은 아이콘을 확인해 보세요.

30개 이상의 생명과학 분야에 걸친 50,000개 이상의 아이콘을 검색하세요.

search icon
arrow-right
syringe,needle,injection,inject,vaccine,vaccination,barrel,medicine,drug,gavage,needle,syringe
더 보기

동의어를 검색하거나 가입하여 앱에서 아이콘을 요청해 보세요.

이미지 유형

Syringe (small, 1/2 liquid) icon JPEG

Syringe (small, 1/2 liquid) icon PNG

Syringe (small, 1/2 liquid) icon SVG

Syringe (small, 1/2 liquid) icon GIF

BioRender 아이콘 FAQ

How are scientists using the Syringe (small, 1/2 liquid) icon in their work?

BioRender users often use the Syringe (small, 1/2 liquid) icon in posters, grant applications, educational materials, and graphical abstracts. It’s especially useful for projects involving Lab and Objects.

이 아이콘을 BioRender 그림이나 과학 일러스트레이션에 사용할 수 있나요?

Yes, the Syringe (small, 1/2 liquid) is fully integrated into BioRender’s drag-and-drop platform. You can easily add it to any scientific figure, workflow, or poster, whether you’re building from scratch or starting with a BioRender template.

Is the Syringe (small, 1/2 liquid) icon customizable in BioRender?

Most icons in BioRender, including the Syringe (small, 1/2 liquid) icon, are customizable. You can adjust icon size, colors, and positioning, and add custom labels to tailor the design to your specific research context.

Can I export figures that include the Syringe (small, 1/2 liquid) icon for publication or presentations?

Yes, figures containing the Syringe (small, 1/2 liquid) icon can be exported in multiple formats, including PNG, JPG, PDF, and SVG. High-resolution and vector exports are available on paid plans, making them ideal for journals, slide decks, and print materials.

How do I cite BioRender if I use this icon?

Unlock publication permissions with a paid plan, and include 'Created with BioRender.com' in your figure legend, or cite BioRender directly per your journal's guidelines.

Is the Syringe (small, 1/2 liquid) icon used in BioRender templates or poster layouts?

Many BioRender templates include icons like the Syringe (small, 1/2 liquid) icon — especially those focused on Lab and Objects. You can search BioRender’s template library or add this icon manually to any canvas.

BioRender란 무엇인가요?

BioRender is a web‑based software that helps you create scientific figures in minutes. Use this Syringe (small, 1/2 liquid) icon along with our library of more than 30,000 life science icons.

BioRender에서 이 아이콘 사용하기

지금 바로 전문가 수준의 과학 피규어를 만들어 보세요
antibody elements3D Phospholipid illustration

과학 콘텐츠를 찾고 계신가요?

동료 검토를 거쳐 사용하기 쉽고 무료로 제공되는 5만 개 이상의 아이콘과 템플릿을 살펴보세요.

지금 바로 찾아보세요
x icon